Group One Trading’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-99,110	Closed	-$522K	–	8884
2025 Q3	$420K	Buy	99,110 +32,914	+50%	+$124K	0.01%	3871
2025 Q2	$140K	Buy	+66,196	New	+$99K	﹤0.01%	4677
2024 Q2	–	Sell	-542	Closed	-$1.65K	–	7398
2024 Q1	$1.29K	Buy	+542	New	+$1.02K	﹤0.01%	6578
2021 Q2	–	Sell	-2,976	Closed	-$10.6K	–	8603
2021 Q1	$6K	Sell	2,976 -5,000	-63%	-$11.2K	﹤0.01%	7199
2020 Q4	$18K	Buy	+7,976	New	+$20.9K	﹤0.01%	5569
2020 Q3	–	Sell	-4,824	Closed	-$13.5K	–	6518
2020 Q2	$15K	Buy	4,824 +65	+1%	+$164	﹤0.01%	4949
2020 Q1	$9K	Buy	+4,759	New	+$11.6K	﹤0.01%	4595
2019 Q4	–	Sell	-794	Closed	-$2.76K	–	5488
2019 Q3	$3K	Sell	794 -14,768	-95%	-$53.4K	﹤0.01%	4855
2019 Q2	$65K	Buy	+15,562	New	+$67.4K	0.01%	3628
2019 Q1	–	Sell	-4,965	Closed	-$23.8K	–	5161
2018 Q4	$17K	Sell	4,965 -42,000	-89%	-$201K	﹤0.01%	4082
2018 Q3	$282K	Sell	46,965 -61,526	-57%	-$339K	0.02%	2756
2018 Q2	$690K	Buy	108,491 +103,339	+2,006%	+$503K	0.05%	2038
2018 Q1	$24K	Buy	+5,152	New	+$24K	﹤0.01%	4011
2017 Q4	–	Sell	-23,052	Closed	-$58.3K	–	5112
2017 Q3	$49K	Buy	+23,052	New	+$45.7K	﹤0.01%	3648